TABLE 1.
Antibody ID | Peptide ID | AA positions in proteins | Peptide sequence | Specificity | Labeling | Accessibility |
---|---|---|---|---|---|---|
Anti-1-01 | 1-01 | 32–46 | ILVQDSAPSADGSLK | Stylin-01 | + | PAc |
Anti-1-05 | 1-05 | 21–35 | PAGQSPESRAVILVQ | Stylin-01 | + | Em |
Anti-1-06 | 1-06 | 38–52 | APSADGSLKNNFQTD | Stylin-01 | + | PAc |
Anti-1-07 | 1-07 | 32–46 | SQEQEVNFDGNFKNK | Stylin-02 | + | PAc |
Anti-1-08 | 1-08 | 48–62 | NFQTDNGIKQEEVRY | Stylin-01 | − | NA |
Anti-1-09 | 1-09 | 59–73 | EVRYLKAGPEGPVSV | Stylin-01 | − | NA |
Anti-1-10 | 1-10 | 92–106 | YVADENGYQPYGAHL | Stylin-01 | + | Em |
Anti-1-11 | 1-11 | 121–135 | RYLASLPSTPEPKYQ | Stylin-01/02 | + | Ac |
Anti-1-13b | 1-13 | 108–122 | TPPPIPAEIQESLRY | Stylin-01/02 | + | Em |
106–120 | LPTPPPIPAEIQESL |
ID, identifier; AA, amino acid; Ac, epitope exposed at the surface and directly accessible; PAc, epitope poorly accessible (labeling either weak or visible as dots without chitinase treatment); Em, epitope embedded, not accessible at the surface of the stylets (labeling visible only after chitinase digestion); NA, not applicable, because of the total lack of labeling regardless of the treatment. +, labeling observed at the tip of maxillary stylets; −, no labeling detected regardless of the tested conditions.
Due to poor immunogenicity prediction, two partially overlapping peptides were used for immunization.